Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Antoaneta Necheva"'
Autor:
Margaret S. Lee, Kenneth C. Anderson, Alexis A. Borisy, Constantine S. Mitsiades, Francis J. Giles, Jennifer S. Carew, Steffan T. Nawrocki, Vikram Kansra, William Avery, Mei Chen, David Crowe, Antoaneta Necheva, Douglas W. McMillin, Melissa Farwell, Laura T. Pierce, Thomas P. Giordano, Winnie F. Tam, Richard J. Rickles
PDF file, 849KB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9d49cd27075b4da2a937cc85271b90e
https://doi.org/10.1158/1535-7163.22499248.v1
https://doi.org/10.1158/1535-7163.22499248.v1
Autor:
Margaret S. Lee, Kenneth C. Anderson, Alexis A. Borisy, Constantine S. Mitsiades, Francis J. Giles, Jennifer S. Carew, Steffan T. Nawrocki, Vikram Kansra, William Avery, Mei Chen, David Crowe, Antoaneta Necheva, Douglas W. McMillin, Melissa Farwell, Laura T. Pierce, Thomas P. Giordano, Winnie F. Tam, Richard J. Rickles
PDF file, 85KB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::358805eaa2fea0bf560d57a0c9c93bfc
https://doi.org/10.1158/1535-7163.22499251.v1
https://doi.org/10.1158/1535-7163.22499251.v1
Autor:
Laura Pierce, Melissa Farwell, Mei Chen, Antoaneta Necheva, Constantine S. Mitsiades, Alexis Borisy, Douglas W. McMillin, Thomas Giordano, Margaret S. Lee, Winnie F. Tam, William Avery, Vikram Kansra, Francis J. Giles, Kenneth C. Anderson, Richard Rickles, David Crowe, Steffan T. Nawrocki, Jennifer S. Carew
Publikováno v:
Molecular Cancer Therapeutics. 11:1432-1442
The use of combination drug regimens has dramatically improved the clinical outcome for patients with multiple myeloma. However, to date, combination treatments have been limited to approved drugs and a small number of emerging agents. Using a system
Autor:
Thomas Giordano, Antoaneta Necheva, Winnie F. Tam, Richard Rickles, Margaret S. Lee, Alexis Borisy
Publikováno v:
Blood. 114:3762-3762
Abstract 3762 Poster Board III-698 By using a high throughput combination screening strategy, we made the surprising discovery that adenosine A2A and beta-2 adrenergic receptor (b2AR) agonists have synergistic anti-proliferative activity in combinati